Brain tumor, breast cancer, colon cancer, congenital heart disease, heart arrhythmia. See more conditions.
Dr. Hobday conducts clinical and translational research in neuroendocrine tumors (NET) in conjunction with basic scientists and pathologists at Mayo Clinic and other academic institutions.
He has been the principal investigator on several multi-center clinical trials, testing novel therapies for these uncommon diseases. He is a member of the National Cancer Institute NET task force, which is charged with leading the development of research initiatives throughout the country for NETs.
In addition, Dr. Hobday has extensive experience in clinical research of novel therapies for breast cancer, including phase II and phase III trials in the adjuvant and metastatic setting.
Learn about clinical trials that address specific scientific questions about human health and disease.
See my studies.
Explore all research studies at Mayo Clinic.
See the peer-reviewed findings I have published as a result of my research.
Review my research fingerprint, network, grants, projects, publications, Scopus profile, and Altmetrics scores and badges.
Mayo Clinic is a nonprofit organization and proceeds from Web advertising help support our mission. Mayo Clinic does not endorse any of the third party products and services advertised.
A single copy of these materials may be reprinted for noncommercial personal use only. "Mayo," "Mayo Clinic," "MayoClinic.org," "Mayo Clinic Healthy Living," and the triple-shield Mayo Clinic logo are trademarks of Mayo Foundation for Medical Education and Research.